Bersani, F. S., Wolkowitz, O. M., Lindqvist, D., Yehuda, R., Flory, J., Bierer, L. M., . . . Mellon, S. H. (2016). Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation. Brain, behavior, and immunity, 52(oct 26), 153-160. https://doi.org/10.1016/j.bbi.2015.10.015
Chicago Style (17th ed.) CitationBersani, Francesco Saverio, et al. "Global Arginine Bioavailability, a Marker of Nitric Oxide Synthetic Capacity, Is Decreased in PTSD and Correlated with Symptom Severity and Markers of Inflammation." Brain, Behavior, and Immunity 52, no. oct 26 (2016): 153-160. https://doi.org/10.1016/j.bbi.2015.10.015.
MLA (9th ed.) CitationBersani, Francesco Saverio, et al. "Global Arginine Bioavailability, a Marker of Nitric Oxide Synthetic Capacity, Is Decreased in PTSD and Correlated with Symptom Severity and Markers of Inflammation." Brain, Behavior, and Immunity, vol. 52, no. oct 26, 2016, pp. 153-160, https://doi.org/10.1016/j.bbi.2015.10.015.